North America Patient Controlled Injectors Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Product (Electronic Injectors, Mechanical Injectors, and Infusion Pumps); Application (Cancer Treatment, Auto-immune Treatment, Blood Disorders Treatment, and Others); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Mail Order Pharmacies); and Country
Market Introduction
Patient controlled Injectors are subcutaneous drug delivery systems that adhere to the body and administer larger volumes (more than 2 mL) of a drug over an extended period. With the use of patient-controlled injectors, dosing errors, microbial contamination risks, and needle stick injuries can be avoided that are caused during parenteral drug administration using injections. In the last few years, the pharmaceutical industry has witnessed the introduction of several innovative interventions for the treatment of various chronic diseases.
Get more information on this report :
Market Overview and Dynamics
The North America patient controlled injectors market is expected to reach US$ 3,236.46 million by 2027 from US$ 1,261.43 million in 2019. The market is anticipated to grow at a CAGR of 12.6% during 2019–2027. The increasing chronic diseases prevalence, and conventional drug delivery system limitations are the major factors expected to boost the growth of the patient controlled injectors market in North America. However, the market is likely to get impacted by the risk factor such as preference of alternative drug delivery during the forecast period.
Key Market Segments
In terms of products, the electronic injector segment accounted for the largest share of the North America patient controlled injectors market in 2019. In terms of application, the cancer treatment segment accounted for the largest share of the North America patient controlled injectors market in 2019. In terms of distribution channel, the hospital pharmacies segment accounted for the largest share of the North America patient controlled injectors market in 2019.
Major Sources and Companies Listed
Several major primary and secondary sources associated with the North America patient controlled injectors market report are the World Health Organization (WHO), Global Burden of Disease (GBD), Centers of Disease Control and Prevention (CDC), American Heart Association (AHA), American Diabetes Association, and others.
Reasons to buy report
- It provides understanding of the North America, patient controlled injectors market landscape and identifies patient controlled injectors market segments that are most likely to guarantee a strong return.
- It guides stay ahead of the race by comprehending the ever-changing competitive landscape for the North America patient controlled injectors market.
- It helps efficiently plan merger and acquisition, and partnership deals in the patient controlled injectors market by identifying market segments with the most promising probable sales
- It facilitates knowledgeable business decision-making through perceptive and comprehensive analysis of patient controlled injectors market performance of various segments pertaining to the North America patient controlled injectors market.
- It provides patient controlled injectors market revenue forecast of the market based on various segments for the period from 2019 to 2027.
NORTH AMERICA PATIENT CONTROLLED INJECTORS MARKET SEGMENTATION
By Products
- Electronic Wearable Injector
- Mechanical Wearable Injector
- Infusion Pumps
By Application
- Cancer Treatment
- Auto-immune Treatment
- Blood Disorders Treatment
- Others
By Distribution Channel
- Retail Pharmacies
- Hospital Pharmacies
- Mail Order Pharmacies
By Country
- US
- Canada
- Mexico
Company Profiles
- Johnson and Johnson Services, Inc.
- West Pharmaceutical Services, Inc
- Enable Injections.
- scPharmaceuticals Inc
- United Therapeutics Corporation
- BD
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Patient Controlled Injectors Market – By Product
1.3.2 North America Patient Controlled Injectors Market – By Application
1.3.3 North America Patient Controlled Injectors Market – By Distribution Channel
1.3.4 North America Patient Controlled Injectors Market – By Country
2. North America Patient Controlled Injectors Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Patient Controlled Injectors Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Patient Controlled Injectors Market - North America PEST Analysis
4.3 Expert Opinion
5. North America Patient Controlled Injectors Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Increasing Prevalence of Chronic Diseases
5.1.2 Rising Patient Compliance
5.2 Market Restraints
5.2.1 Preference of Alternative Drug Delivery
5.3 Market Opportunities
5.3.1 Technological Advancements and Design Development
5.4 Future Trends
5.4.1 Consolidation of Market
5.5 Impact Analysis
6. Patient Controlled Injectors Market – North America Analysis
6.1 North America Patient Controlled Injectors Market Revenue Forecasts and Analysis
7. North America Patient Controlled Injectors Market Analysis and Forecasts To 2027 – By Product
7.1 Overview
7.2 North America Patient Controlled Injectors Market, By Product 2019 & 2027 (%)
7.2.1 North America Patient Controlled Injectors Market Revenue and Forecasts to 2027, By Product (US$ Mn)
7.3 Electronic Injector
7.3.1 Overview
7.3.2 North America Electronic Injector Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Mechanical Injectors
7.4.1 Overview
7.4.2 North America Mechanical Injectors Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 Infusion Pumps
7.5.1 Overview
7.5.2 North America Infusion Pumps Market Revenue and Forecasts to 2027 (US$ Mn)
8. North America Patient Controlled Injectors Market Analysis – By Application
8.1 Overview
8.2 North America Patient Controlled Injectors Market, By Application 2019-2027 (%)
8.2.1 North America Patient Controlled Injectors Market Revenue and Forecasts to 2027, By Application (US$ Mn)
8.3 Cancer Treatment
8.3.1 Overview
8.3.2 North America Cancer Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
8.4 Autoimmune Disease
8.4.1 Overview
8.4.2 North America Autoimmune Disease Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Blood Disorders Treatment
8.5.1 Overview
8.5.2 North America Blood Disorders Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
8.6 Others
8.6.1 Overview
8.6.2 North America Others Market Revenue and Forecasts to 2027 (US$ Mn)
9. North America Patient Controlled Injectors Market Analysis – By Distribution Channel
9.1 Overview
9.2 North America Patient Controlled Injectors Market, By Distribution Channel 2019-2027 (%)
9.2.1 North America Patient Controlled Injectors Market Revenue and Forecasts to 2027, By Distribution Channel (US$ Mn)
9.3 Hospital Pharmacies
9.3.1 Overview
9.3.2 North America Hospital Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
9.4 Retail Pharmacies
9.4.1 Overview
9.4.2 North America Retail Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
9.5 Mail Order Pharmacies
9.5.1 Overview
9.5.2 North America Mail Order Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
10. Patient Controlled Injectors Market Revenue and Forecasts To 2027 – Geographical Analysis
10.1 North America Patient Controlled Injectors Market Revenue and Forecasts To 2027
10.1.1 Overview
10.1.2 North America: Patient Controlled Injectors Market – Revenue and Forecast to 2027 (USD Million)
10.1.3 North America Patient Controlled Injectors Market, by Product– Revenue and Forecast to 2027 (USD Million)
10.1.4 North America Patient Controlled Injectors Market, by Application– Revenue and Forecast to 2027 (USD Million)
10.1.5 North America Patient Controlled Injectors Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)
10.1.6 North America: Patient Controlled Injectors Market, by Country, 2019 & 2027 (%)
10.1.7 US: Patient Controlled Injectors Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.1 US: Patient Controlled Injectors Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.2 US Patient Controlled Injectors Market, by Product– Revenue and Forecast to 2027 (USD Million)
10.1.7.3 US Patient Controlled Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)
10.1.7.4 US Patient Controlled Injectors Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.1.8 Canada: Patient Controlled Injectors Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.1 Canada: Patient Controlled Injectors Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.2 Canada Patient Controlled Injectors Market, by Products – Revenue and Forecast to 2027 (USD Million)
10.1.8.3 Canada Patient Controlled Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)
10.1.8.4 Canada Patient Controlled Injectors Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.1.9 Mexico: Patient Controlled Injectors Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.1 Mexico: Patient Controlled Injectors Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.2 Mexico Patient Controlled Injectors Market, by Products – Revenue and Forecast to 2027 (USD Million)
10.1.9.3 Mexico Patient Controlled Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)
10.1.9.4 Mexico Patient Controlled Injectors Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
11. Impact of COVID-19 Pandemic on North America Patient Controlled Injectors Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
12. Company Profiles
12.1 West Pharmaceutical Services, Inc.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Johnson and Johnson Services, Inc.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Enable Injections
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 scPharmaceuticals Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 United Therapeutics Corporation
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 BD
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
13. Appendix
13.1 About the Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Patient Controlled Injectors Market Revenue and Forecasts To 2027, By Product (US$ Mn)
Table 2. North America Patient Controlled Injectors Market Revenue and Forecasts To 2027, By Application (US$ Mn)
Table 3. North America Patient Controlled Injectors Market Revenue and Forecasts To 2027, By Distribution Channel (US$ Mn)
Table 4. North America Patient Controlled Injectors Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 5. North America Patient Controlled Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)
Table 6. North America Patient Controlled Injectors Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)
Table 7. US Patient Controlled Injectors Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 8. US Patient Controlled Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)
Table 9. US Patient Controlled Injectors Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 10. Canada Patient Controlled Injectors Market, by Products – Revenue and Forecast to 2027 (USD Million)
Table 11. Canada Patient Controlled Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)
Table 12. Canada Patient Controlled Injectors Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 13. Mexico Patient Controlled Injectors Market, by Products – Revenue and Forecast to 2027 (USD Million)
Table 14. Mexico Patient Controlled Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)
Table 15. Mexico Patient Controlled Injectors Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 16. Glossary of Terms, Patient Controlled Injectors Market
LIST OF FIGURES
Figure 1. Patient Controlled Injectors Market Segmentation
Figure 2. North America Patient Controlled Injectors Market Overview
Figure 3. Electronic Injector Segment Held Largest Share of Product in Patient Controlled Injectors Market
Figure 4. US is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. North America Patient Controlled Injectors Market - Leading Country Markets (US$ Mn)
Figure 6. Patient Controlled Injectors Market - North America PEST Analysis
Figure 7. Patient Controlled Injectors Market Impact Analysis of Driver and Restraints
Figure 8. North America Patient Controlled Injectors market – Revenue Forecasts and Analysis – 2019- 2027
Figure 9. North America Patient Controlled Injectors Market, By Product 2019 & 2027 (%)
Figure 10. North America Electronic Injector Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 11. North America Mechanical Injectors Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 12. North America Infusion Pumps Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 13. North America Patient Controlled Injectors Market, by Application 2019 & 2027 (%)
Figure 14. North America Cancer Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 15. North America Autoimmune Disease Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 16. North America Blood Disorders Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 17. North America Others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 18. North America Patient Controlled Injectors Market, by Distribution Channel 2019 & 2027 (%)
Figure 19. North America Hospital Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 20. North America Retail Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 21. North America Mail Order Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 22. North America: Patient Controlled Injectors Market, by Key Country – Revenue (2019) (USD Million)
Figure 23. North America Patient Controlled Injectors Market Revenue and Forecast to 2027 (USD Million)
Figure 24. North America: Patient Controlled Injectors Market, by Country, 2019 & 2027 (%)
Figure 25. US: Patient Controlled Injectors Market – Revenue and Forecast to 2027 (USD Million)
Figure 26. Canada: Patient Controlled Injectors Market – Revenue and Forecast to 2027 (USD Million)
Figure 27. Mexico: Patient Controlled Injectors Market – Revenue and Forecast to 2027 (USD Million)
Figure 28. Impact of COVID-19 Pandemic in North American Country Markets
- Johnson and Johnson Services, Inc.
- West Pharmaceutical Services, Inc
- Enable Injections.
- scPharmaceuticals Inc
- United Therapeutics Corporation
- BD
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America patient controlled injectors market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the North America patient controlled injectors market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth regional market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.